Advances in Treatment of Chronic Lymphocytic Leukemia (CLL)

*This event is free, but registration is required


Date & Time:

Friday, October 25, 2019
6:30 PM – 8:30 PM (PST)


Holiday Inn Vancouver Centre
711 West Broadway, Vancouver, BC, V5Z 3Y2


DR. Peter HIllmen, MD, PhD

Peter Hillmen, MD, PhD

Dr. Hillmen is a Consultant Haematologist at the Leeds Teaching Hospitals NHS Trust and is based at St. James University Hospital in Leeds, UK. He obtained his medical degree from Leeds Medical School in 1985, followed by general medical training in Leeds. He then spent 2 years at Hammersmith Hospital training in haematology followed by 3 years researching under the supervision of Professor Lucio Luzzatto at the Royal Postgraduate Medical School. He was awarded a Ph.D. by the University of London for research into paroxysmal nocturnal haemoglobinuria (PNH), before completing his training in haematology in Leeds. His clinical and research interests include chronic lymphocytic leukaemia (CLL) and PNH. He is Chairman of the CLL trials subgroup of the National Cancer Research Institute (NCRI), with the responsibility of developing a portfolio of phase II and III studies in CLL for the UK. Dr. Hillmen is also the Chairman of the International PNH Interest Group. He is principal investigator of several national and international phase II and III trials for CLL and PNH.


About admin